Viewing Study NCT06543069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:47 PM
Ignite Modification Date: 2026-02-25 @ 4:38 PM
Study NCT ID: NCT06543069
Status: RECRUITING
Last Update Posted: 2024-08-07
First Post: 2024-08-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Peritoneal Mesothelioma, Advanced View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sintilimab View
None Bevacizumab View
None Pemetrexed View
None Cisplatin View
None Malignant Peritoneal Mesothelioma View